Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P2Et Extract in COVID-19
NCT04410510Phase 3Unknown
- Sponsor
- Hospital Universitario San Ignacio
- Start
- Sep 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of P2Et in coronavirus disease 2019 (COVID-19), sponsored by Hospital Universitario San Ignacio. Status: unknown.
02
Drugs
P2Et
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04410510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04410510.